US EditionPublished • loading... • Updated
Thermo Fisher launches obesity registry to track real-world treatment outcomes
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Thermo Fisher launches obesity registry to track real-world treatment outcomes
Thermo Fisher Scientific has enrolled the first patient in a prospective observational registry designed to generate real-world evidence on obesity treatments. The regirstry includes anti-obesity medications and GLP-1 receptor agonists. The PPD CorEvitas Obesity Registry will collect longitudinal data from both clinicians and patients. It will track how therapies are used in practice, how long… The post Thermo Fisher launches obesity registry to…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
